Sodium Phosphate, Dibasic

60 interactions 4 explained in plain English
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Burosumab-Twza Injection Levofloxacin Injection Oxaliplatin Injection Alfuzosin Goserelin Implant Arsenic Trioxide
1 Contraindicated 58 Major 1 Moderate
All (60) Contraindicated (1) Major (58) Moderate (1)

Contraindicated

Sodium Phosphate, Dibasic Burosumab-Twza Injection Crysvita Increased risk of hyperphosphatemia Details

Major

Sodium Phosphate, Dibasic Amitriptyline Elavil Explained An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Sertraline Explained An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Buprenorphine Belbuca Explained An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Sodium Phosphate, Dibasic Arsenic Trioxide Trisenox An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Aripiprazole Injection Abilify An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Arsenic Trioxide Injection Trisenox An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Asenapine Transdermal Patch Secuado Increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Azithromycin AzaSite An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Alfuzosin UroXatral An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Anagrelide Agrylin Increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Bedaquiline Sirturo Increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Chloroquine Aralen® An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Dasatinib Phyrago An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Degarelix Injection Firmagon Increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Disopyramide Norpace An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Dofetilide Tikosyn An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Dolasetron Anzemet An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Dolasetron Injection Anzemet An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Encorafenib Braftovi Increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Erdafitinib Balversa Altered serum phosphate levels Details Sodium Phosphate, Dibasic Flecainide Tambocor® An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Foscarnet Injection Foscavir Increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Fostemsavir Rukobia Increased risk of torsade de pointes Details Sodium Phosphate, Dibasic Gatifloxacin Ophthalmic Zymar® An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Gemifloxacin Factive An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Glasdegib Daurismo Increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Goserelin Implant Zoladex Increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Granisetron Transdermal Patch Sancuso An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Granisetron Injection Granisol An increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Histrelin Implant Supprelin Increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Hydroxychloroquine Plaquenil Increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Inotuzumab Ozogamicin Injection Besponsa Increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Ivabradine Corlanor Increased risk of QT prolongation Details Sodium Phosphate, Dibasic Ketoconazole Topical Extina® Foam Increased risk of QT interval prolongation Details Sodium Phosphate, Dibasic Lefamulin Xenleta Increased risk of QT interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.